Ovagen

Also known as: Liver Bioregulator, Hepatic Peptide Bioregulator

A Khavinson bioregulator peptide for liver health and hepatic function.

Overview

Ovagen is a synthetic tripeptide from the Khavinson bioregulator family designed to support liver function. It may help normalize hepatocyte function and support liver health during aging, after illness, or with metabolic stress.

Mechanism of Action

Gene regulatory effects on hepatocytes. Proposed to normalize protein synthesis in liver tissue. May support detoxification pathways and liver regeneration.

Pharmacokinetics

Small peptide allows oral/sublingual administration. Tissue-specific effects on liver.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Liver Support

Dose

10-20 mg

Frequency

1-2x daily

Duration

10-30 days

2-3 courses per year

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Liver detox

Synergy: Hepatic support plus antioxidant

Research Areas

Liver HealthHepatoprotectionDetoxificationFatty LiverMetabolic SupportLiver Aging

Key Research Findings

  • 1Improved liver function markers in studies
  • 2Support for hepatocyte health
  • 3Gene expression modulation in liver tissue
  • 4Part of metabolic bioregulator protocols

Side Effects & Contraindications

Reported Side Effects

  • Generally well-tolerated

Contraindications

  • None well-established

Safety Considerations

Generally well-tolerated. Limited Western clinical data. May complement liver support treatments.

Storage Requirements

Store at room temperature

Scientific References

Quick Reference

Sequence
Glu-Asp-Leu
Molecular Weight
~375 g/mol
Half-Life
Short
Bioavailability
Oral/sublingual
Research Stage
clinical phase 2
Administration
Oral or sublingual